STUART DIAMOND - 01 Jul 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Stuart Diamond
Issuer symbol
BIAF
Transactions as of
01 Jul 2024
Transactions value $
$0
Form type
4
Filing time
02 Jul 2024, 18:47:14 UTC
Previous filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +33.8K +51.73% $0.00 99.1K 01 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.